Bolyn Hubby

1.6k total citations
20 papers, 942 citations indexed

About

Bolyn Hubby is a scholar working on Immunology, Molecular Biology and Epidemiology. According to data from OpenAlex, Bolyn Hubby has authored 20 papers receiving a total of 942 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 10 papers in Molecular Biology and 5 papers in Epidemiology. Recurrent topics in Bolyn Hubby's work include Immunotherapy and Immune Responses (9 papers), RNA Interference and Gene Delivery (5 papers) and Bacteriophages and microbial interactions (3 papers). Bolyn Hubby is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), RNA Interference and Gene Delivery (5 papers) and Bacteriophages and microbial interactions (3 papers). Bolyn Hubby collaborates with scholars based in United States and France. Bolyn Hubby's co-authors include W. Martin Kast, Andrew Gray, María de la Luz García-Hernández, Matthew J. Sylte, David L. Suarez, Jonathan Smith, Peter Berglund, Kurt I. Kamrud, E. Magda Barbu and Kyle C. Cady and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Bolyn Hubby

20 papers receiving 856 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bolyn Hubby United States 15 410 351 188 185 180 20 942
Erez Bar‐Haim Israel 22 571 1.4× 519 1.5× 294 1.6× 146 0.8× 359 2.0× 59 1.4k
Nicolas Çuburu United States 21 761 1.9× 294 0.8× 309 1.6× 356 1.9× 254 1.4× 33 1.5k
Megan C. Wise United States 17 485 1.2× 284 0.8× 222 1.2× 155 0.8× 171 0.9× 29 902
Anna Flace Switzerland 8 670 1.6× 553 1.6× 171 0.9× 126 0.7× 135 0.8× 10 1.3k
Charlotte Pollard Belgium 13 427 1.0× 439 1.3× 76 0.4× 122 0.7× 172 1.0× 18 829
Jeff Fairman United States 19 208 0.5× 368 1.0× 72 0.4× 187 1.0× 182 1.0× 44 914
T-C Wu United States 17 499 1.2× 271 0.8× 167 0.9× 333 1.8× 63 0.3× 20 901
Eugene V. Barsov United States 15 357 0.9× 485 1.4× 137 0.7× 204 1.1× 203 1.1× 28 1.1k
Shintaro Kobayashi Japan 18 320 0.8× 376 1.1× 114 0.6× 187 1.0× 427 2.4× 62 1.3k
Kiichi Kajino Japan 22 596 1.5× 770 2.2× 172 0.9× 275 1.5× 276 1.5× 46 1.8k

Countries citing papers authored by Bolyn Hubby

Since Specialization
Citations

This map shows the geographic impact of Bolyn Hubby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bolyn Hubby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bolyn Hubby more than expected).

Fields of papers citing papers by Bolyn Hubby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bolyn Hubby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bolyn Hubby. The network helps show where Bolyn Hubby may publish in the future.

Co-authorship network of co-authors of Bolyn Hubby

This figure shows the co-authorship network connecting the top 25 collaborators of Bolyn Hubby. A scholar is included among the top collaborators of Bolyn Hubby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bolyn Hubby. Bolyn Hubby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Wei, Angela C. Evans, Amy Rasley, et al.. (2020). Cationic HDL mimetics enhance in vivo delivery of self-replicating mRNA. Nanomedicine Nanotechnology Biology and Medicine. 24. 102154–102154. 13 indexed citations
2.
He, Wei, Angela C. Evans, Jia Geng, et al.. (2017). Cell-free production of a functional oligomeric form of a Chlamydia major outer-membrane protein (MOMP) for vaccine development. Journal of Biological Chemistry. 292(36). 15121–15132. 30 indexed citations
3.
Kannan, Krishna, John Gill, Bolyn Hubby, et al.. (2017). Digital-to-biological converter for on-demand production of biologics. Nature Biotechnology. 35(7). 672–675. 56 indexed citations
4.
Hubby, Bolyn, et al.. (2017). Engineered bacteriophage therapeutics against multidrug‐resistant pathogens. The FASEB Journal. 31(S1). 1 indexed citations
5.
Barbu, E. Magda, Kyle C. Cady, & Bolyn Hubby. (2016). Phage Therapy in the Era of Synthetic Biology. Cold Spring Harbor Perspectives in Biology. 8(10). a023879–a023879. 51 indexed citations
6.
Galloway, Ashley L., Andrew Murphy, Joseph M. DeSimone, et al.. (2012). Development of a nanoparticle-based influenza vaccine using the PRINT® technology. Nanomedicine Nanotechnology Biology and Medicine. 9(4). 523–531. 69 indexed citations
7.
Osada, Takuya, Peter Berglund, Michael A. Morse, et al.. (2012). Co-delivery of antigen and IL-12 by Venezuelan equine encephalitis virus replicon particles enhances antigen-specific immune responses and antitumor effects. Cancer Immunology Immunotherapy. 61(11). 1941–1951. 20 indexed citations
8.
Xu, Jing, Jin Wang, J. Christopher Luft, et al.. (2012). Rendering Protein-Based Particles Transiently Insoluble for Therapeutic Applications. Journal of the American Chemical Society. 134(21). 8774–8777. 58 indexed citations
9.
Morse, Michael A., Amy Hobeika, Takuya Osada, et al.. (2010). An alphavirus vector overcomes the presence of neutralizing antibodies and elevated numbers of Tregs to induce immune responses in humans with advanced cancer. Journal of Clinical Investigation. 120(9). 3234–3241. 96 indexed citations
10.
Berglund, Peter, et al.. (2010). Effect of a novel recombinant alphaviral vector on tolerance to self-antigen in the setting of elevated regulatory T cells.. Journal of Clinical Oncology. 28(15_suppl). 2544–2544. 2 indexed citations
11.
12.
Koh, Yi Ting, et al.. (2009). Androgen ablation augments prostate cancer vaccine immunogenicity only when applied after immunization. The Prostate. 69(6). 571–584. 77 indexed citations
13.
García-Hernández, María de la Luz, et al.. (2008). Prostate Stem Cell Antigen Vaccination Induces a Long-term Protective Immune Response against Prostate Cancer in the Absence of Autoimmunity. Cancer Research. 68(3). 861–869. 138 indexed citations
14.
Kamrud, Kurt I., Chasity D. Andrews, Whitney Lewis, et al.. (2008). Analysis of Venezuelan Equine Encephalitis Replicon Particles Packaged in Different Coats. PLoS ONE. 3(7). e2709–e2709. 9 indexed citations
15.
García-Hernández, María de la Luz, Andrew Gray, Bolyn Hubby, & W. Martin Kast. (2007). In vivo Effects of Vaccination with Six-Transmembrane Epithelial Antigen of the Prostate: A Candidate Antigen for Treating Prostate Cancer. Cancer Research. 67(3). 1344–1351. 92 indexed citations
16.
Nishimoto, Kevin, Kehui Wang, Kurt I. Kamrud, et al.. (2007). Restricted and Selective Tropism of a Venezuelan Equine Encephalitis Virus-Derived Replicon Vector for Human Dendritic Cells. Viral Immunology. 20(1). 88–104. 30 indexed citations
17.
Hubby, Bolyn, Todd Talarico, Maureen F. Maughan, et al.. (2007). Development and preclinical evaluation of an alphavirus replicon vaccine for influenza. Vaccine. 25(48). 8180–8189. 59 indexed citations
18.
Sylte, Matthew J., Bolyn Hubby, & David L. Suarez. (2007). Influenza neuraminidase antibodies provide partial protection for chickens against high pathogenic avian influenza infection. Vaccine. 25(19). 3763–3772. 65 indexed citations
19.
Wang, Kehui, et al.. (2007). VRP immunotherapy targeting neu: treatment efficacy and evidence for immunoediting in a stringent rat mammary tumor model. Breast Cancer Research and Treatment. 106(3). 371–382. 13 indexed citations
20.
Hubby, Bolyn, et al.. (1995). Construction and use of a multi-competitor gene for quantitative RT-PCR using existing primer sets. Journal of Immunological Methods. 181(2). 145–156. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Erez Bar‐Haim Breakdown of academic impact, for papers by Nicolas Çuburu Breakdown of academic impact, for papers by Megan C. Wise Breakdown of academic impact, for papers by Anna Flace Breakdown of academic impact, for papers by Charlotte Pollard Breakdown of academic impact, for papers by Jeff Fairman Breakdown of academic impact, for papers by T-C Wu Breakdown of academic impact, for papers by Eugene V. Barsov Breakdown of academic impact, for papers by Shintaro Kobayashi Breakdown of academic impact, for papers by Kiichi Kajino
Rankless by CCL
2026